Number of brain metastasis

Slides:

Advertisements

Similar presentations

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.

Advertisements

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.

Triple-Negative Breast Cancer

Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.

The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.

2 years later, she noticed multiple cm

SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Appendix Supplementary data (online only) to: Marleen Kok, Wilbert Zwart, Caroline Holm, Renske Fles, Michael Hauptmann, Laura J. Van ’t Veer, Lodewyk.

First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.

HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C,

Snyder D, Heidel RE, Panella T, Bell J, Orucevic A University of Tennessee Medical Center – Knoxville Departments of Pathology, Surgery, and Medicine BREAST.

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

Supplementary Table 1: Clinicopathologic characteristics of 100 patients with invasive breast cancer Clinical characteristicsNumber of cases (%) Median.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer Slideset on: Piccart-Gebhart M, Procter M, Leyland- Jones B, et al. Trastuzumab.

and Statistics, 2016, Vol. 4, No. 1, 1-8. doi: /ajams-4-1-1

Case 3 Jane McNicholas Consultant Oncoplastic Breast Surgeon

Insert Footer or Copyright Information Here

Figure 1. Correlation between estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression in primary breast tumors and synchronous axillary.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,

Figure 5. Hepatoprotective effects of propolis against DOX-induced toxic effects. Photomicrograph of rats’ liver section of group III (Propolis-DOX treated.

Ari Brooks, MD Cancer Surgeon, Big Data End User

Nurdianah HF, Nizuwan A, Muhamad Yusri M

Prognostic significance of tumor subtypes in male breast cancer:

Anatomic sites(lymph node)

Figure 2. DNA methylation mediated MORT gene silencing is linked to luminal, receptor positive breast cancers. (A) MORT expression level plotted versus.

Ductal Carcinoma (Breast Cancer)

Research, 2015, Vol. 3, No. 6, doi: /education

RADIOLOGICAL AND HISTOPATHOLOGICAL CHARACTERISTIC FEATURES OF BREAST CANCER PATIENTS IN HOSPITAL SERDANG Lim SN.1, Nuratika B.1, Suraini M.S.2, Norafida.

BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.

Canine invasive mammary carcinoma as a spontaneous model

© The Author(s) Published by Science and Education Publishing.

osteoporosis among the studied working women (n= 365)

Research, 2017, Vol. 5, No. 4, doi: /ajnr-5-4-6

Variable Pharmacy (n=319) Sociology (n=205) Total (n=524) P-values

Marcelo Calil Instituto Brasileiro de Controle do Câncer

Table (1):Relation between lymph node and molecular subtypes.

Supplementary Table 1. (A) S100β Validation set (n=76 ER-positive and ER-negative patients). (B) S100β Validation set (n=59 ER-positive patients). Association.

Figure 1. Trial profile. From: Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer Ann Oncol. 2006;17(4): doi: /annonc/mdl001.

Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like.

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

© The Author(s) Published by Science and Education Publishing.

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

Figure 1. Representative photomicrographs of liver section from premalignant HCC and control groups. (A) Animals treated with DENA and CCl4. (B) Cross.

Table 2. Showing mean and SD along with t- critical ratio

Table 1. The Demographic Characteristics

Stamatia Destounis, MD, FACR, FSBI, FAIUM

Age-sex literacy rates by various surveys.

FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. FMRP is.

Age-sex employments by various surveys.

GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR

Table 2. Showing mean and SD along with t- critical ratio

Table 1. Diagnostic methods for systemic fungal infection (n=70)

Group Male Female Total Astrocytoma Grade 2 (%65)13 (%35)7 (%100)20

© The Author(s) Published by Science and Education Publishing.

Table 2. Demographic characteristics of the study subjects

© The Author(s) Published by Science and Education Publishing.

MRNA expression IL-1α, IL-1β, IL-1Ra, IL-1RtI, ER α, ER β, and PR was analyzed by RT-PCR as described in “Materials and Methods.” Representative gel electrographies.

Figure 3. Immunohistochemistry assay for Mfn2 in each group

Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening Trial.

chemistry that are involved in peer group

Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer An imaging-based predictive model.

© The Author(s) Published by Science and Education Publishing.

Table 1. Illiteracy distribution by Gender and Place (No. in million)

Compressive Strength difference at 1 week (MPa)

Twice daily regimen N=45 MDI regimen N=28 P Value

Educational Attainment

Presentation transcript:

Number of brain metastasis Table 1. The characteristics for the breast cancer patients with brain metastasis (n=17) Parameter n(%) Mean±SD Range Age(year) Sex Male Female ER Positive Negative PR Her-2 Ki67 <10%* ≥10% P53 Histological Grade I II III Size of Tumor(cm) 0.1-2 2.1-5 >5 Laterality Right Left Both Lymph node Metastasis Fatty Liver Hormone therapy Radiotherapy Chemotherapy Number of brain metastasis Single Multiple Mastectomy Yes No 0(0) 17(100) 8(47.1) 9(52.9) 10(58.8) 7(41.2) 4(23.5) 13(76.5) 9(62.5) 3(17.6) 6(35.3) 11(64.8) 12(70.6) 5(29.4) 1(5.9) 16(94.1) 13(76.4) 4(23.6) 15(88.2) 2(11.8) 11(64.7) 47.0±14.0 27-73 ER: Estrogen Receptor PR: Progesterone Receptor Her-2: Human Epidermal Growth Factor Receptor 2 * low Ki67 Mehrnoush Aeinfar et al. Clinicopathology Figures of Breast Cancer Women with Brain Metastasis and Invasive Ductal Carcinoma. American Journal of Cancer Prevention, 2015, Vol. 3, No. 3, 68-71. doi:10.12691/ajcp-3-3-6 © The Author(s) 2015. Published by Science and Education Publishing.